Compare ADMA Biologics Inc (ADMA) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Wendys Co — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Wendys Co trades at $7.55 (market cap $1.44B). The key difference: ADMA Biologics Inc is the larger of the two by market cap, and Wendys Co pays a 3.71% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | WEN | |
|---|---|---|
Market Cap | $2.22B | $1.44B |
Sector | Health | Consumer Cyclical |
52-Week High | $20.38 | $10.68 |
52-Week Low | $7.60 | $6.17 |
Enterprise Value | $2.29B | $5.17B |
Dividend Yield | — | 3.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
